Tomasz Świtaj

Validation of the Joensuu risk criteria for primary resectable gastrointestinal stromal tumour – The impact of tumour rupture on patient outcomes

Piotr Rutkowski, Elżbieta Bylina, Agnieszka Woźniak et al. · European Journal of Surgical Oncology · 2011 · 168 citations

Surgical Oncology, Tumour Rupture, Gastrointestinal Oncology +9

Effective Photoimmunotherapy of Murine Colon Carcinoma Induced by the Combination of Photodynamic Therapy and Dendritic Cells

Ahmad Jalili, Marcin Makowski, Tomasz Świtaj et al. · Clinical Cancer Research · 2004 · 148 citations · Full text

Lovastatin potentiates antitumor activity and attenuates cardiotoxicity of doxorubicin in three tumor models in mice.

Wojciech Feleszko, Ewa Bałkowiec-Iskra, Anna Czajka et al. · PubMed · 2000 · 134 citations

Antitumor Activity, Chemoprevention Strategy, Immunology +17

Preoperative hypofractionated radiotherapy in the treatment of localized soft tissue sarcomas

Hanna Koseła-Paterczyk, Milena Szacht, Tadeusz Morysiński et al. · European Journal of Surgical Oncology · 2014 · 105 citations

Surgical Oncology, Radiation Therapy, Soft Tissue Surgery +4

The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study

Piotr Rutkowski, Elżbieta Bylina, Anna Klimczak et al. · BMC Cancer · 2012 · 94 citations · Full text